Clinical Trial Update: Resolute Integrity US Extended Length Sub-Study(RI US XL) [NA]

View source ↗

Summary

Clinical trial update for an extended length sub-study related to coronary artery disease has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Resolute Integrity US Extended Length Sub-Study (RI US XL)

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2017-11-17